EUVIMEDEUVIMED entdecken
Crossref

Brain and Central Nervous System Cancer Burden in China and G20 Countries: Age- and Sex-Specific Comparative Trends with Future Projections

Zeyu Ma, Minkai Wang, Yanmei Hu, Dongling Pei, Zilong Wang, Xianzhi Liu, Zhenyu Zhang, Fangang Meng, Yuchen Ji

Neuroepidemiology · 06.11.2026

DOI: 10.1159/ned/adwag051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 06.11.2026. Verfasst von Zeyu Ma und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain and central nervous system (CNS) cancers pose a significant global burden, with rising incidence/mortality and marked regional/population disparities. Using GBD 2021 data, we analyzed 1990-2021 burden trends in China and other G20 countries, projecting to 2050 to reveal heterogeneities for targeted strategies.

Methods

Epidemiological data on prevalence, incidence, mortality, and disability-adjusted life years (DALYs) were extracted to calculate age-standardized rates (ASRs) and estimated annual percentage changes (EAPCs). Joinpoint regression models were used to identify trend inflections, and ARIMA models were established to project ASRs through 2050, with analyses performed in R.

Results

China’s age-standardized prevalence (ASPR) and incidence (ASIR) grew faster than G20 nations. By 2021, ASPR reached 21.23/100,000 (EAPC=2.66), and ASIR was 6.12/100,000 (EAPC=0.84, twice the G20 rate). Despite declining mortality (ASDR) and DALYs rates, absolute burdens remained high. East Asian countries (e.g., South Korea, Japan) showed rapid ASIR growth, while Western nations trended stably. Chinese females had faster incidence/prevalence increases, males had higher mortality. Projections show persistent growth in the incidence and prevalence through 2050.

Conclusion

This study confirms that China faces persistent burden growth of brain and CNS cancer. Targeted interventions for high-risk populations, optimization of healthcare resource allocation, and attention to gender differences in disease burden are recommended to narrow health disparities and enhance prevention effectiveness.

Zitieren

APA

Ma, Z., Wang, M., Hu, Y., Pei, D., Wang, Z., Liu, X., Zhang, Z., Meng, F., & Ji, Y. (2026). Brain and Central Nervous System Cancer Burden in China and G20 Countries: Age- and Sex-Specific Comparative Trends with Future Projections. Neuroepidemiology. https://doi.org/10.1159/ned/adwag051

Vancouver

Ma Z, Wang M, Hu Y, Pei D, Wang Z, Liu X, et al. Brain and Central Nervous System Cancer Burden in China and G20 Countries: Age- and Sex-Specific Comparative Trends with Future Projections. Neuroepidemiology. 2026. doi:10.1159/ned/adwag051

BibTeX
@article{Ma2026,
  author = {Ma, Zeyu and Wang, Minkai and Hu, Yanmei and Pei, Dongling and Wang, Zilong and Liu, Xianzhi and Zhang, Zhenyu and Meng, Fangang and Ji, Yuchen},
  title = {Brain and Central Nervous System Cancer Burden in China and G20 Countries: Age- and Sex-Specific Comparative Trends with Future Projections},
  journal = {Neuroepidemiology},
  year = {2026},
  doi = {10.1159/ned/adwag051}
}
Kostenlos starten →